Patienter der planlægger graviditet bør skiftes til alternativ antihypertensiv behandling, der besidder en etablereret sikkerhedsprofil for gravide, medmindre fortsat behandling med ACE- hæmmere/ AIIRA betragtes som essentiel.
Unless continued ACE inhibitor/ AIIRAs therapy is considered essential, patients planning pregnancy should be changed to alternative anti-hypertensive treatments which have an established safety profile for use in pregnancy.